Article

IntraLase unveils 30 kHz laser

Washington, DC &#8212 The new IntraLase FS3 laser and upgrade for existing IntraLase customers increases the speed of the laser to 30 kHz from its current 15 kHz, allowing for faster procedure time, tighter spot placement, and lower energy.

April 17 - Washington, DC - The new IntraLase FS30 laser and upgrade for existing IntraLase customers increases the speed of the laser to 30 kHz from its current 15 kHz, allowing for faster procedure time, tighter spot placement, and lower energy.

The IntraLase FS laser was commercially introduced in 2002 as the first laser available for creating corneal flaps. The laser's unsurpassed precision has now extended its use to new therapeutic applications, specifically the treatment of diseased corneas, the company said in a prepared statement.

The IntraLase laser is so uniquely sensitive to corneal physiology that it is also approved for anterior lamellar keratoplasty and intrastromal ring implantation surgeries, which like LASIK benefit from customized architecture and unsurpassed accuracy, according to the company.

For more information on the IntraLase FS30 laser or to view a live demonstration, please visit IntraLase at ASCRS booth #1005.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.